Finally, limited data are available about other maternal risk factors for birth defects, including genetic or other infectious causes, which might be causal factors for a few of the birth defects reported here. Identification and follow-up care of infants born to mothers with laboratory evidence of possible recent Zika virus infection during pregnancy and infants with possible congenital Zika virus infection can ensure that appropriate intervention services are available to affected infants. If there is concern about infant follow-up or maternal testing is not performed, infant Zika virus testing should be considered. For this reason, in this report, analysis of the subset of pregnancies with laboratory-confirmed recent Zika virus infection was included. Pregnant women with Zika virus exposure and prenatally detected fetal abnormalities or infants with birth defects might be more likely to be tested for Zika virus infection.
French pharma rejects U.S. request for fair price for Zika vaccine
Florida State University via YouTube Florida State University via YouTubeA team of researchers from Florida State University, Johns Hopkins University and the National Institutes of Health found existing drugs that can stop Zika from replicating in the body and from damaging fetal brains. Tests are still needed to determine a specific treatment regimen for Zika. There currently is no medical treatment for Zika. 3:00 Growing spinach leaves into heart tissue, researchers solve major bioengineering problem 2:15 Myron Rolle: From FSU football star to brain surgeon Share Video Video link: Select Embed code: Selectfacebookfacebook twittertwitter email A team of researchers from Florida State University, Johns Hopkins University and the National Institutes of Health found existing drugs that can stop Zika from replicating in the body and from damaging fetal brains.
collected by :Lucy William
To follow all the new news about
No comments:
Post a Comment